Lidokain-Adrenalin Sad (Epinephrine, Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerves, stopping the transmission of pain signals. Epinephrine activates alpha‑adrenergic receptors, causing blood vessels to constrict. This vasoconstriction limits lidocaine absorption, prolongs its anesthetic effect, and reduces bleeding at the treatment site.

The appropriate dose is determined by the prescribing healthcare professional based on the type of procedure, the size of the treatment area, patient weight, and overall health status. Clinicians calculate the amount to stay within safe lidocaine limits and achieve the desired anesthetic duration.

Safety data for this combination in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. The prescriber should evaluate the clinical situation and discuss alternatives if concerns exist.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with plain lidocaine, the addition of epinephrine in Lidokain-Adrenalin Sad provides vasoconstriction, which prolongs the anesthetic effect, reduces systemic absorption, and minimizes intra‑operative bleeding. This can allow lower total lidocaine doses while achieving comparable or longer duration of numbness.

Lidokain-Adrenalin Sad should be stored at room temperature, below 25 °C, in its original container. Protect the solution from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze the product, and keep it out of reach of children.

The solution is administered by a qualified healthcare professional via intramuscular or subcutaneous injection directly into the tissue surrounding the procedural site. The injection technique follows standard aseptic practices, and the volume injected is based on the size of the area to be anesthetized.

Serious risks include severe allergic reactions (anaphylaxis), cardiac arrhythmias or myocardial ischemia due to epinephrine, and systemic lidocaine toxicity, which can manifest as seizures, respiratory depression, or cardiovascular collapse. Immediate medical attention is required if any of these events occur.

Patients with known hypersensitivity to lidocaine, epinephrine, or any amide‑type local anesthetics should avoid this product. It is also contraindicated in individuals with uncontrolled hypertension, severe cardiac disease, or certain arrhythmias where epinephrine‑induced vasoconstriction could be harmful.